Across TCGA pan-cancer cohorts, TEX37 RNA is linked to patient survival in 15 of 34 cancer types, making it the most broadly survival-associated TEX37 data layer compared with 2 for mutation status.
The strongest signal is observed in cholangiocarcinoma (CHOL), where higher TEX37 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated TEX37 expression acts as an unfavorable survival marker, although some lineages such as OV and LAML show a favorable association.
CHOL, UVM, and UCEC are the cancer types where TEX37 RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.